The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients

被引:8
|
作者
Kim, Kwang-Kyoun [1 ,2 ]
Won, Yougun [2 ,3 ]
Won, Ye-Yeon [4 ]
机构
[1] Stanford Univ, Coll Med, Dept Orthoped Surg, Stanford, CA 94305 USA
[2] Konyang Univ, Sch Med, Dept Orthoped Surg, 158 Gwanjeodong Ro, Deajeon 35365, South Korea
[3] Yonsei Univ, Grad Sch Med, Dept Orthopaed, Seoul, South Korea
[4] Ajou Univ, Sch Med, Dept Orthopaed Surg, Suwon, South Korea
关键词
Low molecular weight heparin; deep vein thrombosis; pulmonary embolism; hip fracture; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; ORTHOPEDIC-SURGERY; RISK-FACTORS; PROPHYLAXIS;
D O I
10.3349/ymj.2016.57.5.1209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aim of this study was to investigate the efficacy of low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in Korean patients who underwent hip fracture surgery (HFS). Materials and Methods: Prospectively, a total 181 cases were classified into the LMWH user group (116 cases) and LMWH non-user group (65 cases). Each group was sub-classified according to fracture types as follows: 81 cases of intertrochanteric fracture (group A: 49, group B: 32) and 100 cases of neck fracture (group C: 67, group D: 33). We compared the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) according to LMWH use. Results: Of the 181 cases, four DVTs were found in the LMWH user groups (1 in group A, and 3 in group C). One case of PE was found in LMWH non-user group D. The incidences of DVT and PE showed no statistically significant differences between the LMWH user and non-user groups (p=0.298 and 0.359, respectively). In subgroup analysis, no statistically significant differences were found between groups A and B and between groups C and D. Conclusion: The administration of LMWH was not effective in the prevention of venous thromboembolism and PE in the Korean patients who underwent HFS.
引用
收藏
页码:1209 / 1213
页数:5
相关论文
共 50 条
  • [1] Does Venous Thromboembolism Affect Rehabilitation after Hip Fracture Surgery?
    Lee, Young-Kyun
    Choi, Yoon-Hee
    Ha, Yong-Chan
    Lim, Jae-Young
    Koo, Kyung-Hoi
    YONSEI MEDICAL JOURNAL, 2013, 54 (04) : 1015 - 1019
  • [2] Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism in pregnancy
    McColl, MD
    Greer, IA
    CURRENT OPINION IN PULMONARY MEDICINE, 2004, 10 (05) : 371 - 375
  • [3] ROLE OF LOW-MOLECULAR-WEIGHT HEPARINS IN THE PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM AFTER SURGERY
    ANDAZ, S
    SHIELDS, DA
    SCURR, JH
    SMITH, PDC
    PHLEBOLOGY, 1994, 9 (01) : 2 - 7
  • [4] Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients A Systematic Review and Meta-analysis
    Tran, Alexandre
    Fernando, Shannon M.
    Carrier, Marc
    Siegal, Deborah M.
    Inaba, Kenji
    Vogt, Kelly
    Engels, Paul T.
    English, Shane W.
    Kanji, Salmaan
    Kyeremanteng, Kwadwo
    Lampron, Jacinthe
    Kim, Dennis
    Rochwerg, Bram
    ANNALS OF SURGERY, 2022, 275 (01) : 19 - 28
  • [5] Delayed surgery after hip fracture affects the incidence of venous thromboembolism
    Taoka, Takuya
    Ohmori, Takao
    Kanazawa, Tomoko
    Toda, Kazukiyo
    Ishihara, Takeshi
    Ito, Yasuo
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
  • [6] Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery
    Jonas Lundkvist
    David Bergqvist
    Bengt Jönsson
    The European Journal of Health Economics, 2007, 8 : 313 - 323
  • [7] Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery
    Lundkvist, Jonas
    Bergqvist, David
    Jonsson, Bengt
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (04): : 313 - 323
  • [8] Low-Molecular-Weight Heparin Versus Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Medicine Patients-A Pharmacoeconomic Analysis
    Wilbur, Kerry
    Lynd, L. D.
    Sadatsafavi, M.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (05) : 454 - 465
  • [9] Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
    Zee, Aniek A. G.
    van Lieshout, Kelly
    van der Heide, Maaike
    Janssen, Loes
    Janzing, Heinrich M. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [10] Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization
    Testroote, Mark
    Stigter, Willem A. H.
    Janssen, Loes
    Janzing, Heinrich M. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (04):